Lilly says retatrutide outperformed Ozempic in diabetes study — STAT News
Eli Lilly said its investigational drug retatrutide proved more effective than Novo Nordisk's Ozempic at reducing A1c levels and body weight in a large study involving people with…
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 28 06:57 ETSource: UA.NEWS
From the source
Read at ua.newsLilly says retatrutide outperformed Ozempic in diabetes study — STAT News
Eli Lilly said its investigational drug retatrutide proved more effective than Novo Nordisk's Ozempic at reducing A1c levels and body weight in a large study involving people with diabetes. STAT News reports .
